← Leaderboards
Jose P. Zevallos
Washington University
$1,638,729
Attributed
$2,956,217
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,110,548 · 4
By mechanism
R01$2,274,334 · 1
P50$2,154,331 · 1
U01$360,643 · 1
T32$321,240 · 1
Top collaborators
- David N Hayes5 shared
- Aadel Chaudhuri1 shared
- Heath Devin Skinner1 shared
Most similar at Washington University
Same institution · by research overlap
- Shadmehr Demehri$14,520,225
- Mary M. Zutter$12,598,946
- Hua Li$3,159,930
- Margaret A Olsen$3,586,779
- Noah Jackson Earland$122,546
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorHead And Neck CancerHead And Neck Squamous Cell CarcinomaOperative Surgical ProceduresHigh RiskCombined Modality TherapyDecision MakingSamplingPersonalized MedicineInterestPredicting ResponseCollaborationsTranscriptome SequencingGenesCessation Of LifeGenomicsHuman PapillomavirusRadiation TherapyChemotherapyDesignClinical DataCommon TreatmentAnatomyData Set
Grant awards (9)
Head and Neck Cancer SPORE$2,154,331
P50 · FY2025 · CA
Preanalytical Validation of Circulating Tumor DNA from Surgical Drain Fluid as a marker of Postoperative Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma$360,643
U01 · FY2025 · CA · contact PI
Postdoctoral Training in Head and Neck Oncology$156,944
T32 · FY2024 · CA · contact PI
Postdoctoral Training in Head and Neck Oncology$164,296
T32 · FY2023 · CA · contact PI
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer$497,785
R01 · FY2021 · CA · contact PI
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer$392,059
R01 · FY2020 · CA · contact PI
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer$376,150
R01 · FY2019 · CA · contact PI
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer$393,202
R01 · FY2018 · CA · contact PI
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer$615,138
R01 · FY2017 · CA · contact PI